ESR1 rs11229521: What Your Genotype Means
The rs11229521 variant is a single-nucleotide polymorphism located within the ESR1 gene, which encodes the estrogen receptor alpha protein. Research has linked this specific genetic marker to variations in circulating estradiol levels, follicular maturation, and the timing of natural menopause.
What each genotype means
Typical reproductive timing profile
You carry two copies of the common C allele at rs11229521 in the ESR1 gene. Population-level research links this baseline genotype with typical estrogen-mediated signaling and average timing for follicular aging and natural menopause. Because this variant exerts only a modest statistical influence among hundreds of contributing genetic and environmental factors, it does not predict your specific reproductive timeline.
Carried by approximately 55% to 60% of individuals of European ancestry, representing the most common genotype.
Subtle variation in estrogen signaling
You carry one copy of the minor T allele and one copy of the C allele at rs11229521. Large genome-wide association studies have identified modest associations between this allele and slight variations in circulating estradiol concentrations and timing of natural menopause. The overall biological effect of carrying a single copy is very subtle, and scientific evidence remains limited regarding its direct clinical impact.
Carried by roughly 35% to 38% of people of European ancestry.
Altered estrogen signaling profile
You carry two copies of the minor T allele at rs11229521 in the ESR1 gene. Research studies have observed small, incremental shifts in natural menopause timing and circulating estrogen levels associated with carrying two T alleles. However, this finding reflects a modest statistical association across population cohorts rather than a diagnostic indicator of personal hormone levels or ovarian health.
Carried by approximately 5% to 6% of individuals of European descent.
Understanding the rs11229521 Variant
The rs11229521 variant is a specific change in the DNA sequence of the ESR1 gene. In genetics, a single-nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular SNP is situated within the ESR1 gene, which is located on the long arm of chromosome 6 (6q25.1). Because this variant sits within a gene responsible for critical hormonal signaling, researchers study it to understand how subtle differences in our genetic code might influence biological processes. It is important to note that rs11229521 is just one of many variations found within the complex structure of the ESR1 gene, and its presence does not determine a specific health outcome on its own.
The Role of the ESR1 Gene
The ESR1 gene provides instructions for making the estrogen receptor alpha protein. This protein acts as a ligand-activated transcription factor, meaning it binds to estrogen and then travels to the cell nucleus to turn specific genes on or off. This process is fundamental to many physiological functions, including growth, metabolism, and the development of the reproductive system. Because estrogen signaling is so widespread, the ESR1 gene is expressed in many tissues beyond the reproductive organs, including the skeleton, the cardiovascular system, and the brain. By regulating the transcription of estrogen-inducible genes, ESR1 helps maintain homeostasis in these systems. Disruptions or variations in this gene can influence how effectively the body responds to estrogen, which is why it is a frequent subject of study in reproductive health and oncology.
Research and Associations
Scientific research has investigated the association between rs11229521 and various reproductive traits. Studies have suggested that this variant may be linked to differences in circulating estradiol levels and the process of follicular maturation, which is the development of ovarian follicles. Furthermore, some research indicates that variations in the ESR1 gene, including this SNP, are associated with the age at which a woman reaches natural menopause. However, the evidence strength for these associations is currently considered limited. While large-scale studies have identified statistical correlations, these findings often show small effect sizes and can vary significantly between different populations. It is essential to view these associations as statistical trends observed in large groups rather than as predictive tools for individual health outcomes.
Population Frequency
The frequency of the rs11229521 variant varies across different ancestral groups. According to data from the Genome Aggregation Database (gnomAD), the minor allele frequency for this variant is approximately 0.24 across European populations. This means that a significant portion of the population carries at least one copy of the minor allele. Because allele frequencies are not uniform globally, researchers must account for ancestry when studying the impact of this variant. Understanding these frequencies helps scientists determine whether a genetic association is consistent across diverse groups or if it is specific to certain populations.
Interpreting Your Genetic Information
If you have received information about your rs11229521 genotype, it is important to understand what this means in a practical context. Genetic associations with complex traits like the age of menopause are influenced by a combination of many different genes, environmental factors, and lifestyle choices. A single SNP like rs11229521 provides only a tiny fraction of the total picture. You cannot use this information to diagnose a medical condition or predict your personal reproductive health timeline. If you have concerns about your hormonal health, fertility, or the timing of menopause, the most appropriate step is to consult with a healthcare professional or a reproductive endocrinologist. They can provide personalized guidance based on your clinical history and current health status, which are far more informative than any single genetic variant.
How common is this variant?
The minor allele frequency for rs11229521 is approximately 0.24 across European populations in gnomAD.
Frequently asked questions
Does the rs11229521 variant cause early menopause?
No, this variant does not cause menopause. It is statistically associated with variations in the age of natural menopause, but it is only one of many genetic and environmental factors that influence this timing.
Can I use this SNP to predict my fertility?
No, you cannot use this SNP to predict fertility. Fertility is a complex trait influenced by many biological and environmental factors, and this variant does not provide a diagnostic or predictive result.
Is rs11229521 related to breast cancer risk?
While the ESR1 gene is known to play a role in breast cancer, the specific association between the rs11229521 variant and breast cancer risk is not established as a clinical diagnostic marker.
Should I change my medication based on this genotype?
No. You should never change your medication or dosing based on genetic information without first discussing it with your clinician or pharmacist.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11229521?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ESR1
This variant in the estrogen receptor 1 gene is associated with human reproductive behavior and influences estrogen-responsive gene expression.
This variant in the estrogen receptor 1 gene is associated with an increased risk of endometriosis and may influence cognitive aging.
Variant in estrogen receptor 1 associated with variation in female reproductive timing, including age at menarche and natural menopause onset.
Common polymorphism in estrogen receptor alpha (ESR1) affecting target tissue responsiveness to estrogen, recurrent pregnancy loss risk, and bone-reproductive axis interactions.
Estrogen receptor 1 regulatory variant associated with variation in timing of menarche and bone density response to sex hormones.
Estrogen receptor 1 missense and intronic regulatory variation associated with ovarian responsiveness and fertilization rates in assisted reproductive technology.